UMB Bank, n.a. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 294 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
UMB Bank, n.a. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$23,576
-44.9%
1,524
-44.1%
0.00%
-100.0%
Q2 2023$42,794
-4.7%
2,7240.0%0.00%0.0%
Q1 2023$44,892
+203954.5%
2,724
+92.1%
0.00%
Q4 2022$22
-99.9%
1,418
-51.0%
0.00%
-100.0%
Q3 2022$37,000
-42.2%
2,895
-35.8%
0.00%0.0%
Q2 2022$64,000
-13.5%
4,506
-12.0%
0.00%0.0%
Q1 2022$74,000
+13.8%
5,120
+7.8%
0.00%0.0%
Q4 2021$65,0004,7500.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2023
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders